Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis' Pre
Yahoo! Finance: Commodity News
SAN DIEGO----Metabasis Therapeutics, Inc. announced today that Mark Erion, PhD, the Companyâ??s president, chief executive officer and chief scientific officer as well as a member of its board of directors, has resigned as an officer and director of the Company effective October 31, 2009.
Bookmark this thread using these popular bookmarking services